A startup from UCF’s School of Medicine applying exosome technology to regenerative medicine, drug delivery, non-invasive diagnostics, and medical device development. It aims to improve quality of life through innovative healthcare solutions for intractable diseases.
アカデミアにて研究開発された医療技術の展開を行うアメリカ・セントラルフロリダ大学医学部発ベンチャー(株)プロジェニサイトジャパン（本社：神戸市、代表取締役CEO：徐綾）は、この度COVID-19 診断の為のネ...
弊社はセントラルフロリダ大学医学部教授・同大学脳神経科学研究所所長の菅谷公伸博士が研 究開発を行った化合物及び最先端の医療技術（国際特許数・２８、申請中を含めると６０以上）の 市場展開を行ってゆき...
A startup efficiently recovering electricity and high-purity CO₂ from biomass using wet chemical looping technology. Creating value from untapped resources, contributing to realizing a decarbonized society and solving energy challenges.
Development of air and other gas separation technologies and sales of related products.
A Kyoto-based startup has developed the world's first cell therapy enabling nerve regeneration using ES/iPS cell-derived Schwann cells. This breakthrough enables large-scale production of cells previously difficult to mass-produce, paving the way for clinical trials.
A startup overcoming challenges in exosome purification with proprietary high-purity, high-yield technology, offering end-to-end support from research to manufacturing. It accelerates practical applications in drug discovery, contributing to a new foundation for pharmaceutical development and driving medical innovation.
